International Cannabis Weekly: 67

• Lithuanian parliament votes to legalise medicinal cannabis use.
• Wayland signs a 9,000kg supply agreement to export cannabis to Germany.
• Alpha-Cannabis Germany sells 25% stake to Organigram Holdings.
• Nine notable figures who are leading the European cannabis space.
• Industry leaders to convene in Frankfurt at capital market conference.
• UK campaigners encourage medical cannabis access for all conditions.
• Cronos partners with Israel’s Technicon to develop cannabinoid skincare.
• Jersey publishes new legislation for prescribing medical cannabis.
• The UK should emulate Canada and legalise cannabis for all uses.
• New French Minister of the Interior supports cannabis reform.
• Prohibition Partners is presenting at IC3 in New York and 3CM in Frankfurt next week.

• Latin America has the potential to become the largest cannabis supplier in the world.
• Aphria completes first shipment of cannabis oil for clinical study in Argentina.
• The Green Organic Dutchman and LLACA Grupo enter a joint venture in Mexico.
• Support for cannabis decriminalisation is growing across the Caribbean.
• Saint Lucia Labour Party pushes for the legalisation of medical cannabis.

• New Zealand Health Ministry working towards a 2020 date for legal medical cannabis.
• Australian politics are inhibiting the burgeoning cannabis industry.
• Bod Australia is trialling sublingual cannabis wafers to deliver CBD.

• Canada legalises cannabis for recreational adult use.
• Canadian cannabis legalisation will affect countries across the world.
• How the first day of legal cannabis unfolded in Canada.
• Canadian cannabis companies experience shortages in wake of October 17th.
• Aphria intends to list on the New York Stock Exchange.
• iAnthus and MPX Bioceutical announce merger.
• Canopy Growth purchases US hemp researcher Evergreen.
• Together Pharma is developing cannabis growth facilities in Uganda.
• Facebook is removing the ban on cannabis and cannabis-related search results.

• Companies rush to patent genetically modified cannabis molecules.
• Israeli lab set up to give clinical validation to cannabis research.
• Spanish study finds more evidence that cannabis eases the symptoms of MS.

Prohibition Partners is pleased to announce the release of The LATAM Cannabis Report™. The report explores the medical, recreational, and industrial cannabis industries across the $12.7 billion market. The report is the most comprehensive review of the industry to date, identifying the regulatory guidelines and analysing market data across 11 LATAM states